This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Thromboxane A2

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Thromboxanes are synthesised predominantly by platelets and act to promote:

  • vasoconstriction
  • platelet aggregation
  • bronchoconstriction in lung

The key thromboxane is A2 - TXA2 - which degrades spontaneously to the inactive TXB2.

They act as autocoid local hormones due to their short half lives, and they are excreted in the kidney.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.